OnCo
trialsTrial

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

A phase 3 trial of H101 oncolytic adenovirus in Hepatocellular carcinoma, run by Sun Yat-sen University, with a status the registry has not verified recently.